| Product Code: ETC6748543 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Neurotherapeutics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Neurotherapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 China Neurotherapeutics Market - Industry Life Cycle |
3.4 China Neurotherapeutics Market - Porter's Five Forces |
3.5 China Neurotherapeutics Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 China Neurotherapeutics Market Revenues & Volume Share, By Disorders, 2021 & 2031F |
3.7 China Neurotherapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Neurotherapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in China |
4.2.2 Rising awareness about neurotherapeutics among healthcare professionals and patients |
4.2.3 Technological advancements in neurotherapeutic treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory framework for neurotherapeutics in China |
4.3.2 High cost associated with neurotherapeutic treatments |
4.3.3 Limited access to neurotherapeutic healthcare services in remote areas of China |
5 China Neurotherapeutics Market Trends |
6 China Neurotherapeutics Market, By Types |
6.1 China Neurotherapeutics Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 China Neurotherapeutics Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 China Neurotherapeutics Market Revenues & Volume, By Neurological Drugs, 2021- 2031F |
6.1.4 China Neurotherapeutics Market Revenues & Volume, By Neurological Devices, 2021- 2031F |
6.2 China Neurotherapeutics Market, By Disorders |
6.2.1 Overview and Analysis |
6.2.2 China Neurotherapeutics Market Revenues & Volume, By Peripheral Nervous System Disorders (PNS) Disorder, 2021- 2031F |
6.2.3 China Neurotherapeutics Market Revenues & Volume, By Autonomous Nervous System (ANS) Disorder, 2021- 2031F |
6.2.4 China Neurotherapeutics Market Revenues & Volume, By Central Nervous System (CNS) Disorders, 2021- 2031F |
6.3 China Neurotherapeutics Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 China Neurotherapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 China Neurotherapeutics Market Revenues & Volume, By Neurotherapeutic Centers, 2021- 2031F |
6.3.4 China Neurotherapeutics Market Revenues & Volume, By Clinical Research Organizations, 2021- 2031F |
6.3.5 China Neurotherapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 China Neurotherapeutics Market Import-Export Trade Statistics |
7.1 China Neurotherapeutics Market Export to Major Countries |
7.2 China Neurotherapeutics Market Imports from Major Countries |
8 China Neurotherapeutics Market Key Performance Indicators |
8.1 Number of clinical trials for neurotherapeutics in China |
8.2 Adoption rate of innovative neurotherapeutic treatments in major cities |
8.3 Investment in research and development for neurotherapeutics in China |
9 China Neurotherapeutics Market - Opportunity Assessment |
9.1 China Neurotherapeutics Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 China Neurotherapeutics Market Opportunity Assessment, By Disorders, 2021 & 2031F |
9.3 China Neurotherapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Neurotherapeutics Market - Competitive Landscape |
10.1 China Neurotherapeutics Market Revenue Share, By Companies, 2024 |
10.2 China Neurotherapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here